FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089944696> ?p ?o ?g. }

• W2089944696 endingPage "e24405" @default.
• W2089944696 startingPage "e24405" @default.
• W2089944696 abstract "MUC1 is associated with cellular transformation and tumorigenicity and is considered as an important tumor-associated antigen (TAA) for cancer therapy. We previously reported that anti-MUC1 monoclonal antibody C595 (MAb C595) plus docetaxel (DTX) increased efficacy of DTX alone and caused cultured human epithelial ovarian cancer (EOC) cells to undergo apoptosis. To further study the mechanisms of this combination-mediated apoptosis, we investigated the effectiveness of this combination therapy in vivo in an intraperitoneal (i.p.) EOC mouse model. OVCAR-3 cells were implanted intraperitoneally in female athymic nude mice and allowed to grow tumor and ascites. Mice were then treated with single MAb C595, DTX, combination test (MAb C595 and DTX), combination control (negative MAb IgG3 and DTX) or vehicle control i.p for 3 weeks. Treated mice were killed 4 weeks post-treatment. Ascites volume, tumor weight, CA125 levels from ascites and survival of animals were assessed. The expression of MUC1, CD31, Ki-67, TUNEL and apoptotic proteins in tumor xenografts was evaluated by immunohistochemistry. MAb C595 alone inhibited i.p. tumor growth and ascites production in a dose-dependent manner but did not obviously prevent tumor development. However, combination test significantly reduced ascites volume, tumor growth and metastases, CA125 levels in ascites and improved survival of treated mice compared with single agent-treated mice, combination control or vehicle control-treated mice (P<0.05). The data was in a good agreement with that from cultured cells in vitro. The mechanisms behind the observed effects could be through targeting MUC1 antigens, inhibition of tumor angiogenesis, and induction of apoptosis. Our results suggest that this combination approach can effectively reduce tumor burden and ascites, prolong survival of animals through induction of tumor apoptosis and necrosis, and may provide a potential therapy for advanced metastatic EOC." @default.
• W2089944696 created "2016-06-24" @default.
• W2089944696 creator A5012278873 @default.
• W2089944696 creator A5035939791 @default.
• W2089944696 creator A5051081748 @default.
• W2089944696 creator A5054228071 @default.
• W2089944696 creator A5062094407 @default.
• W2089944696 creator A5077746503 @default.
• W2089944696 creator A5084628085 @default.
• W2089944696 creator A5086810315 @default.
• W2089944696 creator A5086916480 @default.
• W2089944696 date "2011-09-09" @default.
• W2089944696 modified "2023-10-12" @default.
• W2089944696 title "Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model" @default.
• W2089944696 cites W1541668845 @default.
• W2089944696 cites W1542216227 @default.
• W2089944696 cites W1591187753 @default.
• W2089944696 cites W1593844282 @default.
• W2089944696 cites W170685917 @default.
• W2089944696 cites W1849884743 @default.
• W2089944696 cites W1964239959 @default.
• W2089944696 cites W1972027082 @default.
• W2089944696 cites W1974964441 @default.
• W2089944696 cites W1978342819 @default.
• W2089944696 cites W1983534285 @default.
• W2089944696 cites W1992476369 @default.
• W2089944696 cites W1996180957 @default.
• W2089944696 cites W2000269194 @default.
• W2089944696 cites W2004736165 @default.
• W2089944696 cites W2027869020 @default.
• W2089944696 cites W2028588685 @default.
• W2089944696 cites W2029671948 @default.
• W2089944696 cites W2036775886 @default.
• W2089944696 cites W2037339465 @default.
• W2089944696 cites W2038428375 @default.
• W2089944696 cites W2041142804 @default.
• W2089944696 cites W2043103956 @default.
• W2089944696 cites W2044373100 @default.
• W2089944696 cites W2046346032 @default.
• W2089944696 cites W2046386902 @default.
• W2089944696 cites W2050089788 @default.
• W2089944696 cites W2066781414 @default.
• W2089944696 cites W2068513410 @default.
• W2089944696 cites W2081145901 @default.
• W2089944696 cites W2088561077 @default.
• W2089944696 cites W2091221538 @default.
• W2089944696 cites W2093252833 @default.
• W2089944696 cites W2095059158 @default.
• W2089944696 cites W2100425690 @default.
• W2089944696 cites W2115847666 @default.
• W2089944696 cites W2118939806 @default.
• W2089944696 cites W2129949847 @default.
• W2089944696 cites W2133289699 @default.
• W2089944696 cites W2138124620 @default.
• W2089944696 cites W2154175915 @default.
• W2089944696 cites W2154536753 @default.
• W2089944696 cites W2155481602 @default.
• W2089944696 cites W2157595683 @default.
• W2089944696 cites W2158364619 @default.
• W2089944696 cites W2158734599 @default.
• W2089944696 cites W2163122856 @default.
• W2089944696 doi "https://doi.org/10.1371/journal.pone.0024405" @default.
• W2089944696 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3170300" @default.
• W2089944696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21931707" @default.
• W2089944696 hasPublicationYear "2011" @default.
• W2089944696 type Work @default.
• W2089944696 sameAs 2089944696 @default.
• W2089944696 citedByCount "22" @default.
• W2089944696 countsByYear W20899446962012 @default.
• W2089944696 countsByYear W20899446962013 @default.
• W2089944696 countsByYear W20899446962014 @default.
• W2089944696 countsByYear W20899446962015 @default.
• W2089944696 countsByYear W20899446962016 @default.
• W2089944696 countsByYear W20899446962017 @default.
• W2089944696 countsByYear W20899446962018 @default.
• W2089944696 countsByYear W20899446962023 @default.
• W2089944696 crossrefType "journal-article" @default.
• W2089944696 hasAuthorship W2089944696A5012278873 @default.
• W2089944696 hasAuthorship W2089944696A5035939791 @default.
• W2089944696 hasAuthorship W2089944696A5051081748 @default.
• W2089944696 hasAuthorship W2089944696A5054228071 @default.
• W2089944696 hasAuthorship W2089944696A5062094407 @default.
• W2089944696 hasAuthorship W2089944696A5077746503 @default.
• W2089944696 hasAuthorship W2089944696A5084628085 @default.
• W2089944696 hasAuthorship W2089944696A5086810315 @default.
• W2089944696 hasAuthorship W2089944696A5086916480 @default.
• W2089944696 hasBestOaLocation W20899446961 @default.
• W2089944696 hasConcept C121608353 @default.
• W2089944696 hasConcept C126322002 @default.
• W2089944696 hasConcept C147483822 @default.
• W2089944696 hasConcept C150903083 @default.
• W2089944696 hasConcept C159654299 @default.
• W2089944696 hasConcept C190283241 @default.
• W2089944696 hasConcept C203014093 @default.
• W2089944696 hasConcept C207001950 @default.
• W2089944696 hasConcept C2777421810 @default.
• W2089944696 hasConcept C2780427987 @default.
• W2089944696 hasConcept C2780496750 @default.

• next